首頁
最新消息
新聞
相關刊物
關於我們
公司簡介
董事長的話
公司沿革
科學與技術
未來發展
粒線體重建療法
應用領域
產品資訊
粒線體活化因子
粒線體置換
粒線體強化
臨床進度
國際認證
聯繫我們
投資人專區
More
Use tab to navigate through the menu items.
台灣粒線體應用技術股份有限公司
Taiwan Mitochondrion Applied Technology Co.,Ltd
Chinese
Chinese
English
Transplantation of viable mitochondria attenuates neurologic injury after spinal cord ischemia.
Literature Source:J Thorac Cardiovasc Surg. 2019 Nov 14.
Preischemic autologous mitochondrial transplantation by intracoronary injection for myocardial protection.
Literature Source:J Thorac Cardiovasc Surg. 2019 Aug 28.
Mitochondrial transplantation ameliorates acute limb ischemia.
Literature Source:J Vasc Surg. 2019 Jul 25. pii: S0741-5214(19)31188-7.
Effects of Mitochondrial Transplantation on Bioenergetics, Cellular Incorporation, and Functional Recovery after Spinal Cord Injury.
Literature Source:J Neurotrauma. 2018 Aug 1;35(15):1800-1818.
Mitochondrial transplantation: applications for pediatric patients with congenital heart disease.
Literature Source:Transl Pediatr. 2018 Apr;7(2):169-175.
Mitochondrial transplantation strategies as potential therapeutics for
central nervous system trauma.
Literature Source:Neural Regen Res. 2018 Feb;13(2):194-197.
Prospects for therapeutic mitochondrial transplantation.
Literature Source:
Mitochondrion.
2017 Jul;35:70-79.
Mitochondrial transplantation: From animal models to clinical use in
humans.
Literature Source:
Mitochondrion.
2017 May;34:127-134.
Mitochondrial Transplantation in Myocardial Ischemia and Reperfusion
Injury.
Literature Source:
Adv Exp Med Biol. 2017;982:595-619.
Transplantation of autologously derived mitochondria protects the
heart from ischemia-reperfusion injury.
Literature Source:
Am J Physiol Heart Circ Physiol.
2013 Apr 1;304(7):H966-82.